Cohance Lifesciences Announces Chairman Transition With Appointment Of Umang Vohra

Cohance Lifesciences Ltd has confirmed a significant leadership transition with Vivek Sharma stepping down from his role as Executive Chairman. The board has appointed Umang Vohra, a seasoned industry leader, to take over as Chairman, signaling continuity and renewed focus on long-term business objectives.

Leadership Transition

Umang Vohra’s appointment is expected to bring fresh strategic direction to Cohance Lifesciences. His experience in steering large pharmaceutical organizations will be instrumental in driving operational excellence and enhancing shareholder value.

Strategic Implications

The transition reflects the company’s commitment to strong governance and adaptability in a competitive industry. With a focus on innovation, compliance, and global expansion, Cohance Lifesciences aims to consolidate its position as a trusted partner in the life sciences ecosystem.

Key highlights

• Umang Vohra appointed Chairman of Cohance Lifesciences
• Vivek Sharma resigns as Executive Chairman
• Leadership change strengthens governance and strategic focus
• Company targets innovation and global expansion in pharma sector

Sources: Reuters, Exchange filings